Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives

Area of Science:

• Cardiology
• Hematology
• Pharmacology

Background:

• Atrial fibrillation (AF) patients face a high stroke risk.
• Oral anticoagulation is proven effective for stroke reduction in AF.
• Significant undertreatment of oral anticoagulation in AF remains a clinical challenge.

Purpose of the Study:

• To achieve consensus on implementing oral anticoagulation guidelines in AF patients.
• To address barriers to effective anticoagulant therapy in AF.
• To improve guideline adherence and patient outcomes.

Main Methods:

• A multidisciplinary expert panel convened, including cardiologists, hematologists, and primary care physicians from Europe and the US.
• Discussions focused on optimizing oral anticoagulation therapy and guideline implementation for AF.
• Consensus was sought on strategies to enhance treatment adherence and management.

Main Results:

• Enhanced communication of stroke reduction benefits versus bleeding risks is crucial for guideline adherence.
• Vitamin K antagonist therapy benefits in stroke prevention are well-established.
• Dedicated anticoagulation centers and patient self-management models show promise for improving anticoagulation quality.

Conclusions:

• Optimizing oral anticoagulation in AF requires better communication of evidence-based benefits.
• Dedicated management strategies, like anticoagulation clinics or self-management, can improve therapeutic quality.
• These approaches facilitate optimal antithrombotic management, reducing stroke risk in AF patients.